# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA671529 | F | Tested for minimum cytotoxic concentration on virus-induced cytopathicity in E6SM cells | Homo sapiens | 9 | ALA1126836 | cell-based format | Scientific Literature | |
2. | ALA671181 | F | Tested for minimum inhibitory concentration against HSV-1 (KOS strain) in E6SM cells | Homo sapiens | 11 | ALA1126836 | cell-based format | Scientific Literature | |
3. | ALA671183 | F | Tested for minimum inhibitory concentration against Vaccinia virus in E6SM cells | Homo sapiens | 9 | ALA1126836 | cell-based format | Scientific Literature | |
4. | ALA671185 | F | Tested for minimum inhibitory concentration against vesicular stomatitis virus (VSV) in E6SM cells. | Homo sapiens | 2 | ALA1126836 | cell-based format | Scientific Literature | |
5. | ALA695944 | F | Tested for minimum cytotoxic concentration on RSV (respiratory syncytial virus)-induced cytopathicity in HeLa cells | Homo sapiens | 6 | ALA1126836 | cell-based format | Scientific Literature | |
6. | ALA857218 | F | Tested for minimum inhibitory concentration against RSV (respiratory syncytial virus) in HeLa cells | Homo sapiens | 1 | ALA1126836 | cell-based format | Scientific Literature | |
7. | ALA849749 | B | Molar potency ratio was evaluated | Canis lupus familiaris | 70 | ALA1123137 | single protein format | Scientific Literature | |
8. | ALA1273405 | A | Cytotoxicity against human HeLaS3 cells after 7 hrs by celltiter-glo assay | Homo sapiens | 6 | ALA1269004 | cell-based format | Scientific Literature | |
9. | ALA1273406 | A | Cytotoxicity against human HeLaS3 cells after 24 hrs by celltiter-glo assay | Homo sapiens | 5 | ALA1269004 | cell-based format | Scientific Literature | |
10. | ALA1273407 | A | Cytotoxicity against human HeLaS3 cells after 48 hrs by celltiter-glo assay | Homo sapiens | 6 | ALA1269004 | cell-based format | Scientific Literature | |
11. | ALA1273408 | F | Antiviral activity against Poliovirus infected in human HeLaS3 cells assessed as inhibition of viral replication treated 1 hr before infection measured after 2 days | Human enterovirus C | 6 | ALA1269004 | organism-based format | Scientific Literature | |
12. | ALA1273409 | F | Antiviral activity against Dengue virus type 2 in BHK-21 cells assessed as inhibition of viral replication after 24 hrs by luciferase assay | dengue virus type 2 | 6 | ALA1269004 | organism-based format | Scientific Literature | |
13. | ALA1273415 | F | Antiviral activity against Poliovirus infected in human HeLaS3 cells assessed as frequency of viral mutagenesis plaque at 1.62 uM by guanidine resistance assay | Human enterovirus C | 1 | ALA1269004 | organism-based format | Scientific Literature | |
14. | ALA1273416 | F | Antiviral activity against Poliovirus infected in human HeLaS3 cells assessed as frequency of viral mutagenesis plaque at 3.24 uM by guanidine resistance assay | Human enterovirus C | 1 | ALA1269004 | organism-based format | Scientific Literature | |
15. | ALA1930345 | B | Activity of Escherichia coli PNP assessed per mg of protein at 100 uM by UV spectrometric analysis | Escherichia coli | 14 | ALA1926572 | assay format | Scientific Literature | |
16. | ALA1930346 | F | Cytotoxicity against human CCRF-CEM cells after 72 hrs by coulter counting | Homo sapiens | 11 | ALA1926572 | cell-based format | Scientific Literature | |
17. | ALA3755834 | A | Prodrug activation assessed as recombinant human PNP-mediated compound cleavage at 100 uM by reverse phase HPLC analysis | Homo sapiens | 4 | ALA3751814 | single protein format | Scientific Literature | |
18. | ALA3755836 | A | Prodrug activation assessed as recombinant Escherichia coli PNP-mediated compound cleavage at 100 uM by reverse phase HPLC analysis | Escherichia coli | 6 | ALA3751814 | assay format | Scientific Literature | |
19. | ALA3755837 | A | Prodrug activation assessed as recombinant Escherichia coli PNP M64V mutant-mediated compound cleavage at 100 uM by reverse phase HPLC analysis | Escherichia coli | 4 | ALA3751814 | assay format | Scientific Literature | |
20. | ALA3755838 | A | Prodrug activation assessed as recombinant Trichomonas vaginalis PNP-mediated compound cleavage at 100 uM by reverse phase HPLC analysis | Trichomonas vaginalis | 6 | ALA3751814 | assay format | Scientific Literature |